Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07180407

The Post-ICU Pain Study

BACKGROUND: ICU survivors may experience serious psychological, physical and cognitive impairments following ICU admission, collectively termed Post Intensive Care Syndrome (PICS). Persistent pain is an underrecognized component of PICS. Previous research has shown that persistent pain is a profound clinical challenge in ICU survivors, however, research demonstrates conflicting results. Furthermore, no studies have examined the prevalence of persistent pain in ICU survivors in a contemporary Danish ICU setting.

OBJECTIVES: We aim to examine the clinical trajectory, risk factors, and pathophysiology of persistent pain in ICU survivors in Denmark.

DESIGN AND SAMPLE SIZE: The study is designed as a multicenter, prospective, inception cohort study with clinical follow-up. Based on the pre-study sample size calculation, 800 patients will be included. Patients will be contacted by telephone 90 days and 180 days after ICU discharge, and a series of questionnaires regarding pain, sleep quality, affective state and quality of life will be completed. A subgroup of patients will undergo a detailed clinical examination including quantitative sensory testing between 180-365 days after ICU discharge.

POPULATION: Patients will be recruited from 4 Danish ICU departments. Inclusion criteria include adult patients (18 years of age), acute admission to the ICU, and an ICU admission of a minimum of 48 hours.

OUTCOMES: The primary outcome is the prevalence of pain assessed by the Brief Pain Inventory (BPI) at 90 and 180 days after ICU discharge. Secondary outcomes include additional detailed descriptions of pain and daily activity, sleep quality, affective state, quality of life, treatment- and patient-related risk factors, and biomarkers associated with development of persistent pain.

Substudies:

- QST substudy: 80 participants (40 with pain and 40 without pain) recruited from the main cohort will undergo Quantative Somatosensory Testing (QST). The objectives are first, to delineate somatosensory profiles of ICU survivors with and without pain, and second, to examine the presence of neuropathic pain in ICU survivors.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Aalborg University Hospital, Aalborg, Denmark

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult ICU patients ≥18 years of age
  • Acute admission to the ICU
  • ICU length of stay of at least 48 hours

Exclusion criteria

  • Patients transferred from a non-participating ICU
  • Patients with pre-planned admission to the ICU e.g., following elective surgery
  • Patients unable to complete questionnaires, including those who are unable to understand or speak Danish, or patients with severe cognitive deficits.

Treatment and study plan

Primary outcomes

  1. Prevalence of pain

    Time frame: 180 day follow-up

    Patients are defined as having pain if they answer "yes" to question number 1 in the Brief Pain Inventory - Short Form

Secondary outcomes

  1. Brief Pain Inventory - Short Form (BPI-SF)

    Time frame: At follow-up at 90 and 180 days

    Additional components of the Brief Pain Invenstory Short Form

  2. Incidence of new-onset persistent pain after ICU discharge

    Time frame: at 90 and 180 days follow-up

    Definition of new-onset persistent pain: Individuals presenting with pain according to Brief Pain Inventory Short Form at 90 AND 180 days follow-up AND not suffering from persistent pain/using pain medication regularly before ICU admission, as reported by the individual.

  3. Quality of life measured by EuroQol-5-domain 5-level (EQ-5D-5L)

    Time frame: at 90 and 180 days

    The EQ-5D-5L comprises 5 components (mobility, self-care, usual activity, pain/discomfort, and anxiety/depression) which can be rated at 5 levels. Furthermore, a Visual Analog Scale (VAS) documents self-rated health

  4. The Single Item Sleep Quality Scale (SQS)

    Time frame: at 90 and 180 days

    The respondent is asked to rate the overall quality of sleep over a 7-day recall period on a VAS. Respondents are instructed to consider the following components before answering the questionnaire: hours of sleep, night wakings, how easily they fall asleep, how often they wake earlier then needed, and how refreshed they feel when waking. Sleep quality is scored as follows: 0 = terrible, 1-3 = poor, 4-6 = fair, 7-9 = good, and 10 = excellent

  5. Hospital Anxiety and Depression Scale (HADS)

    Time frame: at 90 and 180 days

    It comprises seven questions regarding anxiety and seven questions regarding depressive symptoms. Anxiety and depression are scored separately with recommended cut-off values of 8-10 for possible presence of a mood disorder and >11 for probable presence of a mood disorder

  6. Self-Reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS)

    Time frame: 90 and 180 days

    Only patients answering "yes" to the Brief Pain Inventory Short Form, question number 1, will be asked to fill out the S-LANSS. The tool was created as a clinical tool to identify pain primarily of neuropathic origin, allowing for the differentiation between neuropathic pain and nociceptive pain. It contains 7 items assessing pain quality, sensory changes and specific symptoms commonly associated with neuropathic pain. A score above 12 suggests neuropathic pain

  7. 30-day mortality

    Time frame: 30 days

  8. 90-day mortality

    Time frame: 90 days

  9. 180 days mortality

    Time frame: 180 days

Other outcomes

  1. The Short Physical Performance Battery (SPPB)

    Time frame: between 180 days followup and 360 days.

    QST SUBSTUDY: This test includes a series of tasks designed to examine physical performance. The SPPB requires limited space and takes about 10 minutes to complete. It contains 3 domains (3 m gait speed, 5 times chair stands, and 3 progressive standing balance tasks). Each component is scored separately, and a total score is calculated. The maximum score is 12 indicating little to no mobility impairment

  2. PainDETECT (PD-Q)

    Time frame: between 180 days followup and 360 days

    QST SUBSTUDY: The questionnaire assesses pain intensity (three questions), pain course patterns, the location of pain and presence of radiating pain (via a body chart), and sensory descriptors of pain (seven questions). Scores of 0-12 indicate neuropathic pain component is unlikely, scores of 12-18 indicates results are ambiguous, however a neuropathic component can pe present, and lastly scores of 19-38 indicates neuropathic pain component is likely

  3. QST outcomes

    Time frame: between 180 days followup and 360 days

    QST SUBSTUDY:

    • simple reaction time (seconds)
  4. QST outcomes

    Time frame: between 180 days followup and 360 days

    QST SUBSTUDY:

    • Thermal thresholds: Thresholds are determined by increasing the thermode temperature from baseline 32°C (ramp rate + 1.0 °C/s) until the subject activates the 'stop' button. WDT is defined as the point at which the patient first perceives a sensation of warmth. HPT is defined as the point at which the thermal sensation first turns into pain. The cut-off temperature is 50°C, avoiding the risk of thermal skin injuries
  5. QST outcomes

    Time frame: between 180 days followup and 360 days

    QST SUBSTUDY:

    • Pinprick thresholds and temporal summation (mN)
  6. QST outcomes

    Time frame: between 180 days followup and 360 days

    QST SUBSTUDY:

    • Offset analgesia (numeric rating scale; 0-100).
  7. QST outcomes

    Time frame: between 180 days followup and 360 days

    QST SUBSTUDY:

    • Conditioned pain modulation (seconds): includes the cold pressor test (CPT; conditioning stimulus) and pressure algometry (test stimulus).

Study contacts

Contact information is provided by the study sponsor or research team.

Bennedikte K Madsen, MD

CONTACT

[email protected]

0045

Sponsors and collaborators

Lead sponsor

Zealand University Hospital

Other

Collaborators

  • Aalborg University Hospital

Registry information

Official study title

The Post-ICU Pain Study: a Multicenter, Prospective, Inception Cohort Study

Acronym: PIP

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Sep 18, 2025
Registry last updated
Dec 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.